Åke Örtqvist1, Mia Brytting2, Amy Leval3, Maria-Pia Hergens4. 1. Department of Communicable Disease Control and Prevention, Stockholm County Council, and Karolinska Institutet, Department of Medicine Karolinska Solna, Unit of Infectious Diseases, Stockholm, Sweden. Electronic address: ake.ortqvist@sll.se. 2. Unit for Laboratory Surveillance of Viral Pathogens and Vaccine Preventable Diseases, Department of Microbiology, The Public Health Agency of Sweden, Solna, Sweden. 3. Janssen-Cilag AB, Solna, Sweden(1); Department of Communicable Disease Control and Prevention, Stockholm County Council, Sweden(2); Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden. 4. Department of Communicable Disease Control and Prevention, Stockholm County Council, and Karolinska Institutet, Department of Medicine Karolinska Solna, Unit of Infectious Diseases, Stockholm, Sweden. Electronic address: maria-pia.hergens@sll.se.
Abstract
BACKGROUND: A forty-year debate on the potential negative effects of repeated seasonal influenza vaccination has been inconclusive, with multiple observational studies of various design providing heterogeneous results too inadequate to inform vaccination policy. METHODS: A large population-based cohort study including over one-million observations in individuals over age 65 from six consecutive seasons (2011/12-2016/17) in Stockholm County, Sweden. Current season vaccine effectiveness (VE) against severe, mostly hospital-attended, influenza was assessed using Cox multivariate regression analyses adjusting for demographic variables, comorbidities and previous seasonal influenza vaccination status. RESULTS: In none of the six seasons was VE significantly different in persons vaccinated in the current season only, compared to those who had been vaccinated in both the current and the previous season. Neither were there any differences in VE during the seasons 2014/15-2016/17 when comparing persons vaccinated during the current season only vs. those vaccinated during one-three or four-five previous influenza seasons. In contrast, persons only vaccinated during one or more previous years had no protection during the current season. CONCLUSIONS: Persons above 65 years are the largest group at risk for severe or complicated influenza and policy should support their yearly seasonal influenza vaccination, which is to-date the best preventive measure available for all risk groups. No negative effects of repeated seasonal vaccination were seen in this large population-based cohort of older persons with severe influenza, which strengthens the recommendation that persons belonging to this age group should be vaccinated yearly.
BACKGROUND: A forty-year debate on the potential negative effects of repeated seasonal influenza vaccination has been inconclusive, with multiple observational studies of various design providing heterogeneous results too inadequate to inform vaccination policy. METHODS: A large population-based cohort study including over one-million observations in individuals over age 65 from six consecutive seasons (2011/12-2016/17) in Stockholm County, Sweden. Current season vaccine effectiveness (VE) against severe, mostly hospital-attended, influenza was assessed using Cox multivariate regression analyses adjusting for demographic variables, comorbidities and previous seasonal influenza vaccination status. RESULTS: In none of the six seasons was VE significantly different in persons vaccinated in the current season only, compared to those who had been vaccinated in both the current and the previous season. Neither were there any differences in VE during the seasons 2014/15-2016/17 when comparing persons vaccinated during the current season only vs. those vaccinated during one-three or four-five previous influenza seasons. In contrast, persons only vaccinated during one or more previous years had no protection during the current season. CONCLUSIONS:Persons above 65 years are the largest group at risk for severe or complicated influenza and policy should support their yearly seasonal influenza vaccination, which is to-date the best preventive measure available for all risk groups. No negative effects of repeated seasonal vaccination were seen in this large population-based cohort of older persons with severe influenza, which strengthens the recommendation that persons belonging to this age group should be vaccinated yearly.
Authors: In Young Cho; Jung Eun Yoo; Hyeonyoung Ko; Dong Wook Shin; Ji Won Lee; Hee Jo Baek; Nack-Gyun Chung; Ki Woong Sung; Yun-Mi Song Journal: J Cancer Surviv Date: 2019-11-04 Impact factor: 4.442
Authors: Jeffrey C Kwong; Hannah Chung; James Kh Jung; Sarah A Buchan; Aaron Campigotto; Michael A Campitelli; Natasha S Crowcroft; Jonathan B Gubbay; Timothy Karnauchow; Kevin Katz; Allison J McGeer; J Dayre McNally; David C Richardson; Susan E Richardson; Laura C Rosella; Kevin L Schwartz; Andrew Simor; Marek Smieja; George Zahariadis Journal: Euro Surveill Date: 2020-01
Authors: Ainara Mira-Iglesias; F Xavier López-Labrador; Javier García-Rubio; Beatriz Mengual-Chuliá; Miguel Tortajada-Girbés; Joan Mollar-Maseres; Mario Carballido-Fernández; Germán Schwarz-Chavarri; Joan Puig-Barberà; Javier Díez-Domingo Journal: Int J Environ Res Public Health Date: 2021-01-27 Impact factor: 3.390
Authors: Janna R Shapiro; Huifen Li; Rosemary Morgan; Yiyin Chen; Helen Kuo; Xiaoxuan Ning; Patrick Shea; Cunjin Wu; Katherine Merport; Rayna Saldanha; Suifeng Liu; Engle Abrams; Yan Chen; Denise C Kelly; Eileen Sheridan-Malone; Lan Wang; Scott L Zeger; Sabra L Klein; Sean X Leng Journal: NPJ Vaccines Date: 2021-12-09 Impact factor: 7.344